Director Rossman James sold 137.0K MGNI shares (59.4% of prior holdings) at $18.78 on 2025-06-18 for $2.6M
Rossman James, a director, executed a substantial reduction of his MGNI stake by selling 137.0K shares for $2,572,991.46, leaving him with 93.7K shares—a 59.4% reduction in holdings. The sale at $18.78 occurred when the stock was trading 11.6% below its 52-week high of $21.17, despite a sharp 20.7% rally over the prior 30 days and 40.8% gain over 90 days. His prior sell at this same ticker (2025-02-07) delivered a 90-day return of -23.5%, indicating a pattern of well-timed exits at MGNI; however, that historical accuracy is limited to one prior trade at this ticker. The company's valuation metrics show a P/E of 85.09 on trailing net losses (latest quarter: -$9.6M on $155.8M revenue), suggesting the stock is priced on growth expectations rather than current earnings. This large discretionary sale by a director during a period of stock strength warrants investor attention to whether it reflects confidence levels or broader portfolio considerations.
Director Rossman sold 149.9K MGNI shares at $19.46; retains 219.9K; stock currently at $21.17, near 52-week high.
Rossman James, a Director, sold 149,936 shares (40.5% of his pre-transaction holdings) at $19.46 on 2025-02-07, reducing his stake from 369,856 shares to 219,920 shares. The sale occurred while MGNI trades at $21.17 current price—near its 52-week high of $21.17—and the stock has appreciated +28.6% over 30 days and +55.6% over 90 days, indicating strong recent momentum. Against this backdrop, a significant director stake reduction raises questions about position sizing relative to recent valuation gains, particularly given MGNI's elevated P/E of 176.42 and its full-year unprofitability, which contrast with positive quarterly results ($5.2M net income in the latest quarter) and +7.4% annual revenue growth.
